Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Antibiotic pharmacokinetics in women with twin pregnancy
2024-518564-12-00Phase 4Authorised
- Sponsor
- Medical University of Vienna
- Start
- Dec 2024
- Modality
- Small Molecules, Reversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules, Irreversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of cefazolin, ampicillin, clindamycin and piperacillin + tazobactam in bacterial disease and pregnancy, sponsored by Medical University of Vienna. Primary endpoints: Differences in antibiotic concentration between twin pairs, Antibiotic cord/maternal ratio and 5 more. Planned start Dec 2024; status: authorised.
02
Drugs
cefazolinampicillinclindamycinpiperacillin + tazobactam
03
Conditions
bacterial diseasepregnancy
Beyond the preview
Go deeper on 2024-518564-12-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2024-518564-12-00.